Follow
Houssein Ayoub, Ph.D
Houssein Ayoub, Ph.D
Assistant Professor of Applied Mathematics, Qatar University
Verified email at qu.edu.qa - Homepage
Title
Cited by
Cited by
Year
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants
LJ Abu-Raddad, H Chemaitelly, ...
New England Journal of Medicine, 2021
11212021
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 385 (24), e83, 2021
9122021
Effects of previous infection and vaccination on symptomatic omicron infections
HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ...
New England Journal of Medicine 387 (1), 21-34, 2022
5102022
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ...
Nature medicine 27 (12), 2136-2143, 2021
4782021
Protection against the Omicron variant from previous SARS-CoV-2 infection
HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ...
New England Journal of Medicine 386 (13), 1288-1290, 2022
4362022
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar
H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ...
Nature medicine 27 (9), 1614-1621, 2021
4212021
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 386 (19), 1804-1816, 2022
3962022
Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting
LJ Abu-Raddad, H Chemaitelly, JA Malek, AA Ahmed, YA Mohamoud, ...
Clinical Infectious Diseases 73 (7), e1830-e1840, 2021
2442021
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar
H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ...
Nature communications 13 (1), 3082, 2022
2402022
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ...
EClinicalMedicine 35, 2021
1902021
Severity of SARS-CoV-2 reinfections as compared with primary infections
LJ Abu-Raddad, H Chemaitelly, R Bertollini, ...
New England Journal of Medicine 385 (26), 2487-2489, 2021
1892021
Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar
LJ Abu-Raddad, H Chemaitelly, HH Ayoub, HM Yassine, FM Benslimane, ...
Jama 326 (19), 1930-1939, 2021
1652021
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
LJ Abu-Raddad, H Chemaitelly, HH Ayoub, Z Al Kanaani, A Al Khal, ...
Scientific reports 11 (1), 6233, 2021
1462021
Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions
HH Ayoub, H Chemaitelly, LJ Abu-Raddad
BMC medicine 17, 1-12, 2019
1232019
Protective effect of previous SARS-CoV-2 infection against Omicron BA. 4 and BA. 5 subvariants
HN Altarawneh, H Chemaitelly, HH Ayoub, MR Hasan, P Coyle, ...
New England Journal of Medicine 387 (17), 1620-1622, 2022
1222022
Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses
M Makhoul, HH Ayoub, H Chemaitelly, S Seedat, GR Mumtaz, S Al-Omari, ...
Vaccines 8 (4), 668, 2020
1102020
Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
LJ Abu-Raddad, H Chemaitelly, R Bertollini, ...
New England Journal of Medicine, 2022
992022
Duration of immune protection of SARS-CoV-2 natural infection against reinfection
H Chemaitelly, N Nagelkerke, HH Ayoub, P Coyle, P Tang, HM Yassine, ...
Journal of Travel Medicine 29 (8), taac109, 2022
972022
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses
LJ Abu-Raddad, H Chemaitelly, HM Yassine, FM Benslimane, ...
Journal of travel medicine 28 (7), taab083, 2021
902021
Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
H Chemaitelly, R Bertollini, LJ Abu-Raddad, ...
New England Journal of Medicine 385 (27), 2585-2586, 2021
862021
The system can't perform the operation now. Try again later.
Articles 1–20